Medical image software developer Subtle Medical has been granted the CE Mark for the second generation of its SubtlePET software, which removes noise to improve low-count PET image quality.
Also, the software now can be used with radiopharmaceuticals that target prostate-specific membrane antigen (PSMA) expression and neuroendocrine tumors. The software is vendor-neutral and can be used with any company's PET and PET/CT equipment.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
